content

Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19

The U.S. FDA has issued an Emergency Use Authorization for bebtelovimab, an antibody that demonstrates neutralization against the Omicron variant, Eli Lilly and Company...

Pistoia Alliance launches Women in STEM leadership pilot to support members talent and diversity goals

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has today announced the launch of a new...

Plant Based Cure To Stop COVID And Effects And Also Omicron

Life Science Newswire โ€“ The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19. Its novel plant-based...

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to โ‚ฌ100M for a direct-acting RNA-based therapy against BK Virus

AiCuris Anti-infective Cures AG (AiCuris), a leading company in the discovery and development of drugs against infectious diseases, and Hybridize Therapeutics (Hybridize), focused on...

Berkshire Sterile to offer formulation, lyophilization, and method development services

Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement...

AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting Material

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced an expanded partnership to supply more plasmid DNA (pDNA) starting material...

MaaT Pharma and Skyepharma Have Entered a Partnership to Establish the First Exclusive Microbiome Ecosystem Therapies cGMP Manufacturing Facility in France

MaaT Pharma , French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read